Skip to search.
 TSX Up 0.34% TSX Ventures Up 0.11%

Biogen Inc. (BIIB)

-NasdaqGS
422.92 Up 3.48(0.83%) Apr 20, 4:00PM EDT
|After Hours : 421.12 Down 1.80 (0.43%) Apr 20, 7:53PM EDT
Add to Portfolio
Prev Close:419.44
Open:424.66
Bid:419.00 x 100
Ask:422.75 x 100
1y Target Est:480.67
Beta:0.58
Next Earnings Date:24-Apr-15BIIB Earnings announcement
Day's Range:419.00 - 424.77
52wk Range:275.39 - 480.18
Volume:1,183,283
Avg Vol (3m):1,840,160
Market Cap:99.22B
P/E (ttm):34.19
EPS (ttm):12.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBUp 0.83%99.22B
PFEDown 0.09%214.57B

Key Statistics

Forward P/E (1 yr):21.20
P/S (ttm):10.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :16.97
Quarterly EPS Est (Mar-15) :3.91
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.43

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback